U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032

Overview

The U.S. Human Leukocyte Antigen Typing For Transplant Market is expected to reach a 747.05 USD Million by 2032 and is projected to grow at a CAGR of 13.23% from 2025 to 2032.

Revenue, 2024 (USD Million)
378.34
Forecast, 2032 (USD Million)
747.05
CAGR, 2024 - 2032
13.23%
Report Coverage
U.S.

U.S. Human Leukocyte Antigen Typing For Transplant Market 2018-2032 USD Million

U.S. Human Leukocyte Antigen Typing For Transplant Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 378.34 USD Million
  • Projected Market Size (2032): 747.05 USD Million
  • CAGR (2025-2032): 13.23%

Key Findings of U.S. Human Leukocyte Antigen Typing For Transplant Market

  • The U.S. Human Leukocyte Antigen Typing For Transplant Market was valued at 378.34 USD Million in 2024.
  • The U.S. Human Leukocyte Antigen Typing For Transplant Market is likely to grow at a CAGR of 13.23% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Molecular Assay Technologies in Technology Segment accounted for the largest share of the market with a revenue of 310.66 USD Million
  • The fastest growing segment Hospitals & Transplant Centers in End Users Segment grew Fastest with a CAGR of 14.65% during the forecast period from 2024 to 2032.

U.S. Human Leukocyte Antigen Typing For Transplant Market Scope

U.S. Human Leukocyte Antigen Typing For Transplant Market Segmentation & Scope
Technology
  • Non-Molecular Assay Technologies
  • Molecular Assay Technologies
Products & Services
  • Software & Services
  • Reagents and Consumables
  • Instruments
End Users
  • Independent Reference Laboratories
  • Research Laboratories & Academic Institutes
  • Hospitals & Transplant Centers
Application
  • Research Applications
  • Diagnostic Applications
Transplant Type
  • Hematopoietic Stem Cell Transplant
  • Solid Organ Transplant

U.S. Human Leukocyte Antigen Typing For Transplant Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Million
Market Value in 2024 378.34 USD Million
Market Value in 2032 747.05 USD Million
CAGR (2025-2032) 13.23%
Historic Data 2016-2023
Market Segments Covered Technology,Products & Services,End Users,Application,Transplant Type

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 378.34 USD Million in 2024
    • Key Country: U.S., leading in terms of revenue with value of 378.34 USD Million in 2024.

Segments and Scope

  • U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032, By Technology
    • Molecular Assay Technologies is the largest segment in U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 310.66 USD Million in the year 2024.
    • Molecular Assay Technologies is the Fastest growing segment in U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 13.75 % in forecast period 2025-2032.
  • U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032, By Products & Services
    • Instruments is the largest segment in U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 192.49 USD Million in the year 2024.
    • Reagents and Consumables is the Fastest growing segment in U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 12.27 % in forecast period 2025-2032.
  • U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032, By End Users
    • Hospitals & Transplant Centers is the largest segment in U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 197.80 USD Million in the year 2024.
    • Hospitals & Transplant Centers is the Fastest growing segment in U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 14.65 % in forecast period 2025-2032.
  • U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032, By Application
    • Diagnostic Applications is the largest segment in U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 227.84 USD Million in the year 2024.
    • Diagnostic Applications is the Fastest growing segment in U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 13.98 % in forecast period 2025-2032.
  • U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032, By Transplant Type
    • Solid Organ Transplant is the largest segment in U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 246.83 USD Million in the year 2024.
    • Solid Organ Transplant is the Fastest growing segment in U.S. Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 13.84 % in forecast period 2025-2032.

U.S. Human Leukocyte Antigen Typing For Transplant Market Company Share Analysis

 
Company Name Company Share Analysis
Membrane Solutions, LLC.
Porex
SARTORIUS AG
U.S. Human Leukocyte Antigen Typing For Transplant Market Company Share Analysis

U.S. Human Leukocyte Antigen Typing For Transplant Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Human Leukocyte Antigen Typing For Transplant Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Human Leukocyte Antigen Typing For Transplant Market Company Profiling

U.S. Human Leukocyte Antigen Typing For Transplant Market Company Profiling
Frequently Asked Questions
The U.S. Human Leukocyte Antigen Typing For Transplant Market is segmented based on Segmentation Technology,Products & Services,End Users,Application,Transplant Type.
U.S. Human Leukocyte Antigen Typing For Transplant Market was valued at USD 378.34(Revenue in USD Million) in 2020.
U.S. Human Leukocyte Antigen Typing For Transplant Market is projected to grow at a CAGR of 13.23% during the forecast period of 2024 to 2032.
The Molecular Assay Technologies segment is expected to dominate the U.S. Human Leukocyte Antigen Typing For Transplant Market, holding a largest market share of 310.66 USD Million in 2024

Coming Soon....

U.S. Human Leukocyte Antigen Typing For Transplant Market Scope

U.S. Human Leukocyte Antigen Typing For Transplant Market Segmentation & Scope
Technology
  • Non-Molecular Assay Technologies
  • Molecular Assay Technologies
Products & Services
  • Software & Services
  • Reagents and Consumables
  • Instruments
End Users
  • Independent Reference Laboratories
  • Research Laboratories & Academic Institutes
  • Hospitals & Transplant Centers
Application
  • Research Applications
  • Diagnostic Applications
Transplant Type
  • Hematopoietic Stem Cell Transplant
  • Solid Organ Transplant
Frequently Asked Questions
The U.S. Human Leukocyte Antigen Typing For Transplant Market is segmented based on Segmentation Technology,Products & Services,End Users,Application,Transplant Type.
U.S. Human Leukocyte Antigen Typing For Transplant Market was valued at USD 378.34(Revenue in USD Million) in 2020.
U.S. Human Leukocyte Antigen Typing For Transplant Market is projected to grow at a CAGR of 13.23% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Human Leukocyte Antigen Typing For Transplant Market for final year is USD 747.05 (USD Million).

U.S. Human Leukocyte Antigen Typing For Transplant Market Company Profiling

U.S. Human Leukocyte Antigen Typing For Transplant Market Company Profiling
Frequently Asked Questions
The U.S. Human Leukocyte Antigen Typing For Transplant Market is segmented based on Segmentation Technology,Products & Services,End Users,Application,Transplant Type.
U.S. Human Leukocyte Antigen Typing For Transplant Market was valued at USD 378.34(Revenue in USD Million) in 2020.
U.S. Human Leukocyte Antigen Typing For Transplant Market is projected to grow at a CAGR of 13.23% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Human Leukocyte Antigen Typing For Transplant Market for final year is USD 747.05 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.